Comprehensive in vitro analysis evaluating the variable drug–drug interaction risk of rifampicin compared to rifabutin

Compared to rifampicin (600 mg/day), standard doses of rifabutin (300 mg/day) have a lower risk of drug–drug interactions due to induction of cytochrome P450 3A4 (CYP3A4) or P-glycoprotein (Pgp/ABCB1) mediated by the pregnane X receptor (PXR). However, clinical comparisons with equal rifamycin doses...

Descripción completa

Detalles Bibliográficos
Autores principales: Nilles, Julie, Weiss, Johanna, Sauter, Max, Haefeli, Walter E., Ruez, Stephanie, Theile, Dirk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Organ Toxicity and Mechanisms
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10322781/
https://www.ncbi.nlm.nih.gov/pubmed/37285043
http://dx.doi.org/10.1007/s00204-023-03531-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10322781/
https://www.ncbi.nlm.nih.gov/pubmed/37285043
http://dx.doi.org/10.1007/s00204-023-03531-2

Ejemplares similares